CSIMarket
 
Lemaitre Vascular Inc   (NASDAQ: LMAT)
 
Price: $80.2800 $-0.17 -0.211%
Day's High: $80.94999694824219 Week Perf: 1.66 %
Day's Low: $ 79.05 30 Day Perf: -20.77 %
Volume (M): 282,757 52 Wk High: $ 118.01
Volume (M$): $ 0 52 Wk Avg: $93.97
Open: $79.58 52 Wk Low: $78.27



 Market Capitalization (Millions $) 1,849
 Shares Outstanding (Millions) 23
 Employees 655
 Revenues (TTM) (Millions $) 257
 Net Income (TTM) (Millions $) 62
 Cash Flow (TTM) (Millions $) 2
 Capital Exp. (TTM) (Millions $) 8

Business Description


Lemaitre Vascular Inc. is a leading provider of medical devices for the treatment of peripheral arterial disease (PAD) and other vascular disorders. The company was founded in 1983 and is headquartered in Burlington, Massachusetts.

The mission of Lemaitre Vascular is to improve patient care by providing innovative and high-quality medical devices to healthcare professionals. The company has a wide range of products that are used in the treatment of PAD, including stents, balloons, catheters, and other devices.

Lemaitre Vascular has a global presence, with offices and distribution channels in over 30 countries. The company has a highly skilled team of employees, including engineers, scientists, and healthcare professionals, who work together to develop and market new products and technologies.

In addition to its core product offerings, Lemaitre Vascular is committed to developing new and innovative solutions to address the needs of patients with vascular disorders. The company has a strong focus on research and development, and invests heavily in clinical studies and trials to ensure the efficacy and safety of its products.

Lemaitre Vascular has a reputation for innovation and excellence in the medical device industry, and has received numerous awards and accolades over the years. The company is also dedicated to corporate responsibility, and has implemented several sustainability initiatives aimed at reducing its environmental impact and promoting ethical and responsible business practices.

Overall, Lemaitre Vascular is a highly respected and successful company that has made significant contributions to the field of vascular medicine, and continues to work towards improving patient outcomes through innovative medical devices and technologies.


   Company Address: 63 Second Avenue Burlington 1803 MA
   Company Phone Number: 221-2266   Stock Exchange / Ticker: NASDAQ LMAT


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
BAX   -1.85%    
BDX   -1.38%    
BSX   -1.45%    
EW        0.28% 
SYK   -1.22%    
ZBH   -0.93%    
• View Complete Report
   



Shares

LeMaitre Vasculars Bold Financial Strategy: The Impact of $150M Convertible Senior Notes Offering,

Published Mon, Dec 16 2024 12:58 PM UTC

LeMaitre Vascular s Strategic Move: Convertible Senior Notes Offering and Its Potential ImplicationsOn December 16, 2024, LeMaitre Vascular, Inc. (Nasdaq: LMAT) took a significant step in its financial strategy by announcing a proposed offering of $150,000,000 in Convertible Senior Notes due 2030. This move, which is contingent upon market conditions, is primarily aimed at ...

Product Service News

LeMaitre Vascular Set to Shine at Investor Conferences Following Impressive Q2 Revenue Growth

Published Fri, Nov 3 2023 8:23 PM UTC

LeMaitre Vascular, Inc. (Nasdaq:LMAT) recently announced their participation in three investor conferences set to take place in November. This news comes in the wake of their impressive financial performance in the second quarter of 2023, where the company witnessed a revenue increase of 18.95% year on year. However, this growth falls slightly below the average revenue growt...




Fundamental Analysis

Valuation Current
Price to Earnings PE Ratio (TTM) 30.07
Price to Earnings PE Ratio (Expected) -
Price to Sales (TTM) 7.21
Price to Sales (Expected) -
Price to Book 4.55
PEG (TTM) 0.86

Financial Strength Current
Quick Ratio 11.01
Working Capital Ratio 14.32
Leverage Ratio (MRQ) 0.55
Total Debt to Equity 0.42
Interest Coverage (TTM) 18.75
Debt Coverage (TTM) 0.58

Per Share Current
Earnings (TTM) 2.67 $
Revenues (TTM) 11.14 $
Cash Flow (TTM) 0.07 $
Cash 15.95 $
Book Value 17.66 $
Dividend (TTM) 0.85 $

Efficiency Current
Revenue per Employee (TTM) 391,626
Net Income per Employee (TTM) 95,270
Receivable Turnover Ratio (TTM) 7.42
Inventory Turnover Ratio (TTM) -
Asset Turnover Ratio (TTM) 0.43

Profitability Ratios Current
Gross Margin (MRQ) 72.89 %
Operating Margin (MRQ) 26.77 %
Net Margin (MRQ) 23.61 %
Net Cash Flow Margin (MRQ) -2.1 %
Effective Tax Rate (TTM) 22.59 %

Management Effectiveness Current
Return On Assets (TTM) 10.44 %
Return On Investment (TTM) 10.91 %
Return On Equity (TTM) 16.19 %
Dividend Yield 1.24 %
Pay out Ratio (TTM) 31.84 %



Lemaitre Vascular Inc's Segments
United States    56.01 % of total Revenue
Germany    8.34 % of total Revenue
Canada    6.1 % of total Revenue
United Kingdom    4.71 % of total Revenue
Other countries    25.07 % of total Revenue

  Lemaitre Vascular Inc Outlook

On May 2 2024 the Lemaitre Vascular Inc provided following guidance

LeMaitre Vascular Inc. (Nasdaq: LMAT), a leading provider of vascular devices, implants, and services, announced its financial results for the first quarter of 2024 on May 2nd. The company reported strong performance in the quarter, with revenues exceeding expectations and demonstrating solid growth in key product segments.

In addition to the positive financial results, LeMaitre Vascular Inc. also declared a quarterly dividend of $0.16 per share for the quarter. This dividend reflects the company's continued commitment to returning value to its shareholders and maintaining a strong financial position.

Looking ahead, LeMaitre Vascular Inc. provided guidance for the remainder of 2024, indicating ...





Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.